Future Family Appoints New CEO, Expands IVF Financing Options

Future Family, a leading in vitro fertilization (IVF) financing platform, has announced the appointment of Alden Romney as its new CEO. The company, which has extended over $200 million in financing to more than 10,000 families since its inception in 2016, is poised for its next phase of growth under Romney's leadership.
New Leadership and Strategic Vision
Alden Romney, with two decades of experience in healthcare, including roles at One Medical and various behavioral health and fertility care businesses, takes the helm as Future Family's new CEO. The company's founder and former CEO, Claire Tomkins, will transition to the role of executive chair.
Romney expressed enthusiasm about his new position, stating, "Coming back to partner with Claire and Future Family is a bit like coming home. What's really excited me about this partnership ... is to increase the access and affordability of fertility care for families. It's a really emotional issue."
Innovative Financing Solutions for Fertility Treatment
Future Family has positioned itself as a pioneer in providing financial solutions for couples seeking fertility treatments. With IVF costs often exceeding $20,000 per cycle and limited insurance coverage, the company offers a range of financing options to make fertility care more accessible.
Key features of Future Family's financing program include:
- Loans ranging from $20,000 to $50,000
- Monthly payments starting at $300
- Interest rates from 7.99% to 23.99%
- Zero-interest options for 12-month repayment plans
- 90-day grace period before fund utilization and interest accrual
- Bundled costs covering clinical care, pharmacy, and genetic testing
The company has also launched what it claims is the first nationwide IVF insurance program, "Baby or Your Money Back." This innovative product offers coverage for two IVF cycles or two cycles plus medications, with a money-back guarantee if treatment is unsuccessful.
Expanding Partnerships and Future Growth
Future Family currently partners with 600 fertility clinics across the United States, streamlining the borrowing process for patients. The company also collaborates with independent pharmacies to offer selective discounts on fertility medications.
Recently, Future Family secured $400 million in financing from Clear Haven Capital to scale its operations. This funding is expected to serve approximately 20,000 families seeking fertility treatment.
Looking ahead, the company aims to deepen relationships with clinics and expand its insurance product offerings. Tomkins envisions Future Family as "absolutely a healthcare business" and hints at potential future partnerships with employers and payers to further increase access to fertility care.
As the demand for fertility treatments continues to grow, Future Family is well-positioned to play a crucial role in making these services more affordable and accessible to aspiring parents across the United States.
References
- Future Family, an IVF financing platform, names new CEO
Since 2016, Future Family has extended over $200 million in financing to more than 10,000 families.
Explore Further
What specific strategies or initiatives does Alden Romney plan to implement to further increase access and affordability of fertility care?
What has been the financial performance and growth trajectory of Future Family since its inception in 2016?
What are Alden Romney's notable achievements in his previous roles at One Medical and other healthcare firms that could influence his leadership at Future Family?
How does Future Family's 'Baby or Your Money Back' insurance program compare to similar offerings from other fertility care providers or insurers?
Have there been recent personnel changes or executive appointments at other fertility care or financing companies in the sector, and how might they compare to Future Family's leadership changes?